TB-500: Benefits, Dosage, the BPC-157 Stack, and How to Get It in 2026
Medically reviewed by the Rite Aid Health Team · Last updated
Evidence and status
- Approval status
- Not FDA approved
- Strongest support
- Animal and laboratory research
- Route context
- Reported practice; no established labeled route
- Competitive sport
- Prohibited in sport
TB-500 is a synthetic fragment of thymosin beta-4 studied for cell movement, soft tissue repair, and blood vessel formation. Most supporting evidence comes from animal and laboratory research.
Get the Free Peptide Tracking Toolkit
TB-500 + many more
Explore the guide, then keep the details you verify in the Excel workbook.
Excel workbook
11 worksheets for vials, schedules, labs, storage, and more.
PDF guide
Review providers, products, documents, storage, and travel.
Free download
Useful before or after you start
- Before you start, compare the details that matter and build a focused question list.
- Already using peptides? Keep vials, administration, sites, wellness notes, labs, storage, and travel together.
- Separate your schedule from what actually happened, so important dates are easier to spot.
- Keep your private working copy on your own device.
Confirm your email to receive both downloads and your personal 20% off coupon.
Almost done
We sent the first email to .
Confirm your email to get the toolkit and your 20% off coupon.
We also sent a verification text. Reply YES to confirm your phone number.
-
1
Confirm your email
Open the first email and click the confirmation link.
-
2
Only after step 1
Then the toolkit arrives
We email your Excel workbook and PDF guide right away. Your personal 20% off coupon follows when ordering opens.
The first email should arrive within a minute. Do not see it? Check spam or promotions.
Tell us where to send it
Free, no spam, only peptide news that matters. Unsubscribe anytime.
What is TB-500?
TB-500 is a synthetic peptide based on a fragment of Thymosin Beta-4 (TB-4), a naturally occurring protein found in nearly all human and animal cells.
TB-4 plays a central role in building and recycling actin, one of the structural proteins cells use to move and rebuild tissue. TB-500 reproduces the active region of that protein in a more stable synthetic form. It does not occur in this isolated form in nature.
More precisely, TB-500 is the acetylated seven-amino-acid fragment Ac-LKKTETQ, corresponding to positions 17 through 23 of thymosin beta-4. Product pages often use the two names interchangeably, but research on the full protein does not automatically describe the shorter fragment.
Benefits and uses
Research and reported use focus on four parts of recovery:
- Soft-tissue and muscle regeneration. The most-studied effect. TB-500 promotes cell migration and the actin regulation that lets tissue rebuild, which speeds recovery in animal injury models.
- Blood-vessel formation. It supports angiogenesis — the growth of new blood vessels into healing tissue — improving the blood supply an injury needs to repair.
- Inflammation modulation. TB-500 dampens inflammatory signaling, part of why it is used during recovery.
- Systemic reach. Because Thymosin Beta-4 is present throughout the body, TB-500 is studied for whole-body cell migration and regeneration rather than purely local repair.
Athletes and other users report less soreness, easier movement, and faster returns to training during TB-500 cycles. Those reports explain its recovery reputation. Published research mainly explores the underlying biology in laboratories and animals.
The distinction between TB-500 and full thymosin beta-4 matters here. FDA's 2026 review found that studies submitted for wound healing used the full protein, while no human study had administered TB-500 itself.
How it works
The proposed mechanism centers on actin, the protein that drives cell movement. In thymosin beta-4 research, actin regulation helps repair cells move toward damaged tissue.
Related laboratory work also examines angiogenesis and inflammatory signaling. These mechanisms give researchers concrete recovery questions to test, while direct TB-500 outcome studies remain the missing step.
Dosage and administration
Reported protocols usually use subcutaneous injection and a loading-then-maintenance pattern. A higher loading phase commonly runs for four to six weeks, followed by a lower maintenance phase.
These schedules describe current practice around an unapproved peptide. The amount and frequency vary across clinics, products, and goals.
Freeze-dried vials require reconstitution before use. The peptide dosage calculator converts a supplied dose, vial strength, and water volume into syringe units.
Side effects and safety
Users commonly report injection-site reactions, fatigue, a head rush, or lightheadedness shortly after a dose. These reports describe what people notice, although controlled studies have not measured how often each effect occurs.
FDA found no human exposure data or animal toxicology program for TB-500. It also identified concerns relevant to injectable peptides, including immune reactions, aggregates, impurities, and product sterility.
Legal status and how to get it in 2026
The FDA removed TB-500 from its Section 503A Category 2 list in April 2026.
On , an FDA advisory committee recommended adding it to the Section 503A Bulks List. The committee considered wound healing.
The vote was advisory. It was not drug approval, and the FDA has not made a final decision. Current access rules remain unchanged.
Products sold online for research use are not approved for human use. Their identity, strength, and quality may be uncertain.
Get the Free Peptide Tracking Toolkit
TB-500 + many more
Explore the guide, then keep the details you verify in the Excel workbook.
Excel workbook
11 worksheets for vials, schedules, labs, storage, and more.
PDF guide
Review providers, products, documents, storage, and travel.
Free download
Useful before or after you start
- Before you start, compare the details that matter and build a focused question list.
- Already using peptides? Keep vials, administration, sites, wellness notes, labs, storage, and travel together.
- Separate your schedule from what actually happened, so important dates are easier to spot.
- Keep your private working copy on your own device.
Confirm your email to receive both downloads and your personal 20% off coupon.
Almost done
We sent the first email to .
Confirm your email to get the toolkit and your 20% off coupon.
We also sent a verification text. Reply YES to confirm your phone number.
-
1
Confirm your email
Open the first email and click the confirmation link.
-
2
Only after step 1
Then the toolkit arrives
We email your Excel workbook and PDF guide right away. Your personal 20% off coupon follows when ordering opens.
The first email should arrive within a minute. Do not see it? Check spam or promotions.
Tell us where to send it
Free, no spam, only peptide news that matters. Unsubscribe anytime.
TB-500 vs BPC-157 and why people stack them
TB-500 and BPC-157 are a common reported recovery pairing. Users assign BPC-157 a local repair role and TB-500 a broader cell-migration role.
The BPC-157 and TB-500 stack guide covers reported schedules, blend terminology, and the rationale people use for combining them. The popularity of the pairing runs ahead of direct human research on the combination.
For the broader recovery protocol, compare TB-500 with other healing and recovery peptides, and see KPV for the anti-inflammatory addition.
Blood work to track TB-500
People tracking a TB-500 cycle often combine recovery measures with general blood work. Pain, movement, strength, and return to activity show more about the injury itself.
- hs-CRP — a broad inflammation marker that people follow for a trend over time.
- Comprehensive metabolic profile — liver, kidney, glucose, and electrolyte context during a cycle.
Test at baseline and again at 4–6 weeks.
WADA prohibits TB-500 at all times, including during training and competition.
Peptide Baseline Measurement Panel
Get your baseline- No doctor visit required
- 2,200+ Quest locations
- Results in 1–2 business days
References
Banned in competitive sport. This peptide is prohibited by the World Anti-Doping Agency (WADA), and athletes subject to drug testing can face sanctions for using it. Check current WADA and league rules before considering it.
For general education only — not medical advice or a treatment recommendation. Peptides are not a substitute for care from a licensed provider. Talk to a qualified healthcare professional before you start, stop, or change any peptide, medication, or supplement.
FAQ
Most commonly for soft-tissue and muscle injury recovery — promoting cell migration, regeneration, and blood-vessel formation. The strongest evidence is in animal research; human clinical data is limited.
An FDA advisory committee recommended TB-500 for the Section 503A Bulks List in July 2026. The vote was not drug approval, and the FDA has not made a final decision. Research-only products are not approved for human use.
Protocols commonly use subcutaneous injection in a loading-then-maintenance pattern over 4–6 week blocks, but there is no FDA-approved product or official dosing. Dosing should be set by a prescribing provider.
Reported effects are generally mild — injection-site reactions, fatigue, lightheadedness after a dose. Long-term human safety data does not exist, which is the main caution.
They are commonly used together in reported recovery protocols. Users assign BPC-157 a local-repair role and TB-500 a broader cell-migration role, although the combination has not been tested in controlled human trials.
Protocols typically run in 4–6 week blocks. For an acute injury, users often report effects within the first cycle, and inflammatory markers like hs-CRP may shift within the first few weeks.